Literature DB >> 26667452

Factors Affecting the Use of Human Tissues in Biomedical Research: Implications in the Design and Operation of a Biorepository.

Daniel S Atherton1,2, Katherine C Sexton1,2, Dennis Otali1, Walter C Bell1, William E Grizzle3,4.   

Abstract

The availability of high-quality human tissues is necessary to advance medical research. Although there are inherent and induced limitations on the use of human tissues in research, biorepositories play critical roles in minimizing the effects of such limitations. Specifically, the optimal utilization of tissues in research requires tissues to be diagnosed accurately, and the actual specimens provided to investigators must be carefully described (i.e., there must be quality control of each aliquot of the tissue provided for research, including a description of any damage to tissues). Tissues also should be collected, processed, stored, and distributed (i.e., handled) uniformly under a rigorous quality management system (QMS). Frequently, tissues are distributed to investigators by tissue banks which have collected, processed, and stored them by standard operating procedures (SOPs). Alternatively, tissues for research may be handled via SOPs that are modified to the specific requirements of investigators (i.e., using a prospective biorepository model). The primary goal of any type of biorepository should be to ensure its specimens are of high quality and are utilized appropriately in research; however, approaches may vary based on the tissues available and requested. For example, extraction of specific molecules (e.g., microRNA) to study molecular characteristics of a tissue may require less clinical annotation than tissues that are utilized to identify how the molecular expression might be used to clarify a clinical outcome of a disease or the response to a specific therapy. This review focuses on the limitations of the use of tissues in research and how the design and operations of a tissue biorepository can minimize some of these limitations.

Entities:  

Keywords:  Biorepository; HIPAA; Human tissue; IRB; Limitations; Prospective tissue collection; Research; Tissue banking

Mesh:

Year:  2016        PMID: 26667452     DOI: 10.1007/978-1-4939-3204-7_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

1.  Commentary on Improving Biospecimen Utilization by Classic Biobanks: Identifying Past and Minimizing Future Mistakes.

Authors:  William E Grizzle; Katherine C Sexton
Journal:  Biopreserv Biobank       Date:  2018-12-01       Impact factor: 2.300

2.  Biological, Medical, and Other Tissue Variables Affecting Biospecimen Utilization.

Authors:  Dennis Otali; Sameer Al Diffalha; William E Grizzle
Journal:  Biopreserv Biobank       Date:  2019-06       Impact factor: 2.300

3.  The Utilization of Biospecimens: Impact of the Choice of Biobanking Model.

Authors:  William E Grizzle; Marianna J Bledsoe; Sameer Al Diffalha; Dennis Otali; Katherine C Sexton
Journal:  Biopreserv Biobank       Date:  2019-06       Impact factor: 2.300

4.  Development of the necrotizing enterocolitis society registry and biorepository.

Authors:  Matthew W Ralls; Samir K Gadepalli; Karl G Sylvester; Misty Good
Journal:  Semin Pediatr Surg       Date:  2017-11-06       Impact factor: 2.754

Review 5.  Effects of Cold Ischemia on Gene Expression: A Review and Commentary.

Authors:  William E Grizzle; Dennis Otali; Katherine C Sexton; Daniel S Atherton
Journal:  Biopreserv Biobank       Date:  2016-08-23       Impact factor: 2.300

6.  Acceptable Weight Ranges for Research Tissue Procurement and Biorepositories, 2015-2017.

Authors:  David G Nohle; Randal L Mandt; Marta E Couce; Anil V Parwani; Leona W Ayers
Journal:  Biopreserv Biobank       Date:  2018-10-31       Impact factor: 2.300

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.